Inhibrx is an innovative and outcome-focused brand in the field of biotechnology. As a clinical-stage biotechnology company, we are dedicated to advancing scientific innovation and excellence to help individuals facing life-threatening conditions. Our unique and varied pipeline of therapeutic candidates is anchored by our expertise in protein engineering and our proprietary single-domain antibody platform.

With an agile and proactive approach, we continually strive to make progress in the field of biotherapeutics. Our team consists of proven innovators and collaborators who possess deep scientific and clinical experience in discovering and developing protein therapeutics. We bring new perspectives and thoughtful analysis to every situation, combining the flexibility and spirit of a start-up with the knowledge and expertise of an established brand.

We value partnerships with investors, patients, and other stakeholders, recognizing the importance of collaboration to achieve our goals. If you're interested in learning more about Inhibrx and our exciting developments in the pipeline, we encourage you to reach out to our team. Let us show you how our scientific approach and commitment to innovation can make a difference in the lives of individuals facing critical health challenges